- Display 15 Products per page
Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends)
Published: February 23, 2013 | Price: $3,995.00 – $7,990.00
This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the market for systems that enable labs to store, identify and transport large quantities of specimens. The report analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research laboratories. Many clinical laboratories are facing a number of issues that are challenging their ability to remain competitive. These challenges...
Lab Automation Markets, Outlook 2014-2019, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends)
Published: March 17, 2015 | Price: $1,995.00 – $3,995.00
Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends) Automation technology is an essential consideration in modern laboratory operation and efficiency. In many ways, the technology that supports analysis of large-scale sample sizes is as important as the analytic instruments. This Kalorama Information report, Lab Automation Markets, 4th Edition, analyzes the present and future revenue opportunity for medical laboratory automation systems and equipment – both for the...
Lab Robotics Market: Specimen Transport, Robotic Centrifuges, Capping Robots, Robotic Liquid Handlers, and Other Clinical Laboratory Systems
Published: May 26, 2017 | Price: $3,196.00 – $6,392.00
Lab Robotics Market analyzes the current and potential world revenues for diagnostic laboratory robotic systems. The report's revenue data provide multiple year forecasts for different product segments and revenue forecasts focus on segments where robotics plays an important role, including the following world market segments: The report's market data provide multiple year forecasts for different product segments and market forecasts focus on segments where robotics plays an important role, including the following world market segments: Specimen Transport Robots Systems, 2016-2021...
Laboratory Information Systems (LIS / LIMS): Software, Hardware and Service Markets for Clinical Labs and Drug Discovery Labs
Published: September 19, 2013 | Price: $2,500.00 – $5,000.00
Laboratory Information Systems (LIS / LIMS) Markets (Clinical Laboratory Software and Hardware, Drug Discovery Systems) Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. This Kalorama Information market report, The World Market for Lab Information Systems (LIS) analyzes the current and potential world markets for medical laboratory information system software and hardware -- both for the clinical diagnostics lab and...
Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition
Published: August 1, 2013 | Price: $4,200.00 – $8,400.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients...
Lateral Flow Technology and the Future of Point-of-Care Diagnostics
Published: February 1, 2007 | Price: $1,995.00 – $3,990.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and manufacturing. Rapid point of care testing devices will play an increasingly important role in the decentralization of medicine, where testing is moving away...
Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets
Published: March 26, 2015 | Price: $3,995.00 – $7,990.00
Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets This report, Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets is a detailed analysis of the market opportunity for this important part of next generation sequencing applications The report includes: Market Estimate and Projection for Library Preparation and Target Enrichment Market Share by Company and Competitive Situation More Than 300 Partnerships and Deals in LP/TE New Library Preparation and Target Enrichment Products Significant Trends in the...
Liquid Chromatography Markets (LC, HPLC and UHPLC)
Published: March 1, 2009 | Price: $1,995.00 – $3,990.00
The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography (HPLC) has used essentially the same types of components since the 1980s. However, the market has seen an extraordinary amount of technological change in the last few years as companies have continued to introduce new systems performing fast LC and ultra HPLC (UHPLC). This report, Liquid Chromatography Markets,, represents Kalorama's...
Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living
Published: June 1, 2010 | Price: $3,995.00 – $7,990.00
Kalorama Information publishes its third edition of this detailed report on the long term care industry at a time of growth but also change and concern for the long term care industry. The economy has challenged the business strategies of key players, while the recent healthcare legislation introduces changes that may affect revenues. These twin challenges are addressed in The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living The report provides an in-depth examination of the...
Long-Term Care Market – Nursing Homes, Home Care, Hospice Care, and Assisted Living, The
Published: July 1, 2008 | Price: $3,995.00 – $7,990.00
As Kalorama publishes its second edition of this detailed report on the long term care industry and all of its segments, there is no decrease in demand or activity for everything from nursing homes, to home care, to hospices. The U.S. long care industry has experienced strong growth from 2002 through 2007 and this growth is expected to accelerate through the forecast period as the U.S. population continues to age and demand rises for long term care. Ongoing cost containment...
Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, The
Published: January 1, 2006 | Price: $3,500.00 – $7,000.00
The U.S. long-term care industry experienced strong growth from 1999 through 2004 and this growth is expected to continue through the end of the decade. Indeed, the aging of the U.S. population will push unprecedented demand for all forms of long-term care, but ongoing cost containment issues continue to pressure both private and public managed care organizations and make competition in this dynamic environment challenging. This comprehensive study from Kalorama Information details four segments of the long-term care industry, including:...
Major World Markets for Stents and The Economics of Drug-Eluting Technology
Published: May 1, 2008 | Price: $995.00 – $1,990.00
Since the arrival of drug-eluting (called drug-eluding by some) technology a few years ago with the promise of reducing restenosis, questions abound surrounding the future of the stent market: After numerous clinical studies and mixed cost-effectiveness results, how is drug-eluding technology expected to peform in the future? What can companies do to best market this technology in the healthcare system of the US and 6 other major world markets? What are the market trends to watch that will determine growth...
Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)
Published: April 12, 2021 | Price: $4,000.00 – $8,000.00
Contract manufacturing is an increasing part of the pharmaceutical business. In cell therapy this need is magnified because of the demand for cell and gene therapy products. Kalorama Information's report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following: Biopharmaceutical Contract Manufacturing Market Role Services Offered Usage Drivers Profiles of Companies, Key Players, and Competitors in the Market COVID-19’s Challenges and Opportunities for CMOs Global and Regional Market Overviews—U.S., Europe, and Other Nations New Developments and...
Market for Generic Biologics – Issues, Trends, and Market Potential, 2nd edition, The
Published: November 1, 2005 | Price: $2,500.00 – $5,000.00
Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion (and growing at over 10% per year) to generic competition, if—and it’s a big if—the regulatory hurdles for these generics can be overcome. Biogeneric is a new term combining biologic...
Market for Generic Biologics: Issues, Trends, and Market Potential, The
Published: June 1, 2004 | Price: $1,500.00 – $3,000.00
Biologics, or biopharmaceuticals, are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biogenerics are not generic biologics, because there can technically be no generic form of biologics. That is, the complex process of creating biologics, means that traditional definitions of bioequivalence used in the generic drug industry do not (or may not)...